At this time, posts about iCure are rapidly increasing on portals and stock communities. iCure is known as a company possessing core technology for transdermal drug delivery systems.


As of 12:30 PM on the 9th, iCure's stock price is 60,000 KRW, down 3.69% from the previous day, with a trading volume of 835,020 shares, which is about 46.37% of the 5-day average trading volume. On December 8th, iCure became a market issue with the headline "Stock price plunges over 20% due to disappointment at the extraordinary general meeting."


In addition to iCure, posts from investors are also surging regarding Sinseong ENG (011930), CMG Pharmaceutical (058820), and KEC (092220).



※ Source: AI Investment Assistant AI Rassi


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing